The room data sheet written for the design basis often ends up as the document an inspector checks your monitoring limits against.
It does two different jobs in its life, and each needs different revision control.
At design stage it is an input. Grade, pressure, temperature and RH ranges, process heat, people, equipment, finishes. It changes every week while loads settle and the process team makes up its mind, and it should. The design team owns it. A revision letter and a log are enough.
After qualification it is a record. It holds the values OQ tested against and PQ proved, and the limits the monitoring system alarms on. Now a changed setpoint without a revised sheet means the BMS and the qualified record disagree, and the change belongs under change control, owned by QA.
The trouble starts when nobody decides the moment the sheet changes role. Design keeps editing a file QA already treats as approved. Or QA freezes it before the loads are settled, and the engineers keep a private copy.
EU GMP Annex 15 expects the URS to stay a point of reference through the validation life cycle. The room data sheet is the room-level part of that reference.
We start projects from a set of 34 standard pharma room data sheets and write the URS alongside them. Our view: agree the freeze point before DQ, not at OQ.
At which gate does your room data sheet move under change control?
Industries




